Akathisia — A Brief Review

Haskovee L. L'akathisie, Rev. NeuroL(Paris) 1909; 9: 1107–9.

Halstead S.M. , Barnes TRE , & Speller J.C. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry. 1994; 164: 177–183.

Chung W.S.D. , & Chin HFK Drug induced akathisia revisited Br J Clin Psychiatry. 1996; 50(5): 270–278.

Blaisdell G.D. Akathisia: A comprehensive review and treatment summary. Pharmacopsychiatry 1994; 27: 139–146.

Kasantikul D. , Drug induced akathisia and suicidal tendencies in psychotic patients. J Med AY.Yoc Thai. 1998; 81(7): 551–4.

Drake R.E. , & Erlich J. Suicide attempts associated with akathisia. Am J Psychiatry. 1985; 142(4): 499–501.

Tre Barnes A rating scale for drug induced akathisia. Br J Psychiatry 1989; 1.54: 672–6.

Sachdev P. , The epidemiology of drug induced akathisia: Part i. Acute akathisia. Schizophr Bull. 1995; 21(3): 431–449.8.

Sachdev P. , & Kmk J. Clinical characteristics and predisposing factors in acute drug induced akathisia. Arch Gen Psychiatry. 1994; 51: 963–974.

Miller CAL , & Fleisthacker W.W. Managing antipsychotic induced acute and chronic akathisia. Drugsqf 2000; 22(1): 73–81.

Sachdev P. The epidemiology of drug induced akathisia: Part II. Chronic, tardive and withdrawal akathisias. Schizophr Bull. 1995; 21(3): 451–460.

Farde L , Norstrom XL , Weisel F.A. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry. 1992; 49: 538–544.

Cohen ILM , Keek PL , Sattin A. , & Colt J.O. Prevalence and severity of akathisia in patients on clozapine. Biol Psychiatry. 1991; 29: 1215–1219.

Ekbom K.A. Restless legs syndrome. 1960; Neurol, 10, 868-873.

Barnes T.R.E. , & Braude W.M. Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 1985; 42: 874–879.

Claghorn J , Honigteld G , Abumbah F.S. The risks and benefits of clozapine verses chlorpromazine. J chn psychopharmacol 1987; 7: 377–384.

Sandoz Pharmaceutical Corporation. Hospital Pharmacists Guide to the Clozaril Patient Management System. E. Rutherford, N.J. Sandoz.

Safferman A. , Lieberman A. , Pollack S. (1992). Clozapine and akathisia. Biol Psychiatry. 1991; 31: 753–754.

Miller CM , Molir F , Umbricht D. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapme, risperidone, and conventional antipsychotics. J Clinical Psychiatry. 1998; 59(2): 69–75.

Taylor D , McConnell H , McConnell D. Maudsley prescribing guidelines. 6th edition. Martui Dunitz. London 2001.

Weiss D , Aizeaberg D , Hermesh II. Cyproheptadine treatment in neuroleptic induced akathisia. Br J Psychiatry. 1995; 167(4): 483–6.

Poyurovsky M , Shardorodsky M , Fuchs C , Schneidinan M. , & Weizman A. Treatment of neuroleptic induced akathisia with the SHT2 antagonist mianserin. Br J Psychiatry. 1999; 174: 238–242.

Anfang M.K. , & Pope HG. Treatment of neuroleptic: induced akathisia with nicotine patches. P.Pychopharmacology. 1997; 134(2): 153–6.